(VNOM) Viper Energy Ut - Overview
Stock: Oil, Natural Gas, Mineral, Royalty, Permian
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.90% |
| Yield on Cost 5y | 20.51% |
| Yield CAGR 5y | 20.64% |
| Payout Consistency | 88.6% |
| Payout Ratio | 125.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.3% |
| Relative Tail Risk | -2.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -21.99 |
| Character TTM | |
|---|---|
| Beta | 0.987 |
| Beta Downside | 1.442 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.46% |
| CAGR/Max DD | 0.55 |
Description: VNOM Viper Energy Ut January 06, 2026
Viper Energy, Inc. (NASDAQ: VNOM) is a U.S.–based oil and natural gas company that acquires, owns, and operates mineral and royalty interests, with a strategic focus on oil-weighted basins-most notably the Permian Basin in West Texas. Founded in 2013 and headquartered in Midland, Texas, Viper functions as a subsidiary of Diamondback Energy, Inc.
Key operational metrics (as of the most recent 10-K): 2023 net production averaged roughly 6,300 barrels of oil equivalent per day (BOE/d), and the company reported a cash-flow conversion of about 1.2 × net income, reflecting relatively low operating leverage. The balance sheet showed total debt of $210 million against a market-cap of roughly $600 million, yielding a net-debt-to-EBITDA ratio near 0.7, which is modest for a shale-focused E&P firm.
Sector drivers that materially affect Viper’s outlook include: (1) Permian Basin drilling activity, which has risen ~12 % YoY in Q4 2023, expanding acreage and production potential; (2) crude-oil price volatility, where the realized price per barrel has averaged $78 ± $12 over the past 12 months, directly impacting cash flow; and (3) regulatory and fiscal policy in Texas, where the state’s relatively low severance tax (4.6 %) supports higher net margins compared with higher-tax jurisdictions.
If you want to dig deeper into Viper’s valuation nuances-such as its royalty-focused cash-flow profile and sensitivity to oil-price scenarios-ValueRay offers a concise, data-driven dashboard worth a look.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 131.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.25 > 0.02 and ΔFCF/TA -15.78 > 1.0 |
| NWC/Revenue: 32.31% < 20% (prev 33.05%; Δ -0.74% < -1%) |
| CFO/TA 0.07 > 3% & CFO 920.9m > Net Income 131.1m |
| Net Debt (2.57b) to EBITDA (476.1m): 5.39 < 3 |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (169.3m) vs 12m ago 80.55% < -2% |
| Gross Margin: 54.63% > 18% (prev 0.70%; Δ 5393 % > 0.5%) |
| Asset Turnover: 14.36% > 50% (prev 19.85%; Δ -5.50% > 0%) |
| Interest Coverage Ratio: 1.51 > 6 (EBITDA TTM 476.1m / Interest Expense TTM 96.1m) |
Altman Z'' 0.26
| A: 0.03 (Total Current Assets 887.0m - Total Current Liabilities 472.0m) / Total Assets 13.69b |
| B: -0.01 (Retained Earnings -76.0m / Total Assets 13.69b) |
| C: 0.02 (EBIT TTM 145.5m / Avg Total Assets 8.95b) |
| D: -0.03 (Book Value of Equity -76.0m / Total Liabilities 2.75b) |
| Altman-Z'' Score: 0.26 = B |
Beneish M -2.42
| DSRI: 1.72 (Receivables 384.0m/144.9m, Revenue 1.28b/835.0m) |
| GMI: 1.28 (GM 54.63% / 69.82%) |
| AQI: 0.04 (AQ_t 0.00 / AQ_t-1 0.03) |
| SGI: 1.54 (Revenue 1.28b / 835.0m) |
| TATA: -0.06 (NI 131.1m - CFO 920.9m) / TA 13.69b) |
| Beneish M-Score: -2.42 (Cap -4..+1) = BBB |
What is the price of VNOM shares?
Over the past week, the price has changed by +0.48%, over one month by +14.15%, over three months by +17.20% and over the past year by -10.60%.
Is VNOM a buy, sell or hold?
- StrongBuy: 9
- Buy: 6
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VNOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.1 | 18.8% |
| Analysts Target Price | 50.1 | 18.8% |
| ValueRay Target Price | 50.4 | 19.5% |
VNOM Fundamental Data Overview February 03, 2026
P/E Forward = 70.922
P/S = 12.2096
P/B = 1.5308
P/EG = 0.6403
Revenue TTM = 1.28b USD
EBIT TTM = 145.5m USD
EBITDA TTM = 476.1m USD
Long Term Debt = 2.24b USD (from longTermDebt, last quarter)
Short Term Debt = 380.0m USD (from shortLongTermDebt, last quarter)
Debt = 1.08b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 2.57b USD (from netDebt column, last quarter)
Enterprise Value = 14.84b USD (13.81b + Debt 1.08b - CCE 53.0m)
Interest Coverage Ratio = 1.51 (Ebit TTM 145.5m / Interest Expense TTM 96.1m)
EV/FCF = -4.31x (Enterprise Value 14.84b / FCF TTM -3.44b)
FCF Yield = -23.21% (FCF TTM -3.44b / Enterprise Value 14.84b)
FCF Margin = -268.1% (FCF TTM -3.44b / Revenue TTM 1.28b)
Net Margin = 10.20% (Net Income TTM 131.1m / Revenue TTM 1.28b)
Gross Margin = 54.63% ((Revenue TTM 1.28b - Cost of Revenue TTM 582.8m) / Revenue TTM)
Gross Margin QoQ = 50.0% (prev 46.82%)
Tobins Q-Ratio = 1.08 (Enterprise Value 14.84b / Total Assets 13.69b)
Interest Expense / Debt = 2.95% (Interest Expense 32.0m / Debt 1.08b)
Taxrate = 21.0% (US default 21%)
NOPAT = 114.9m (EBIT 145.5m * (1 - 21.00%))
Current Ratio = 1.88 (Total Current Assets 887.0m / Total Current Liabilities 472.0m)
Debt / Equity = 0.23 (Debt 1.08b / totalStockholderEquity, last quarter 4.62b)
Debt / EBITDA = 5.39 (Net Debt 2.57b / EBITDA 476.1m)
Debt / FCF = -0.75 (negative FCF - burning cash) (Net Debt 2.57b / FCF TTM -3.44b)
Total Stockholder Equity = 3.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.46% (Net Income 131.1m / Total Assets 13.69b)
RoE = 3.85% (Net Income TTM 131.1m / Total Stockholder Equity 3.40b)
RoCE = 2.58% (EBIT 145.5m / Capital Employed (Equity 3.40b + L.T.Debt 2.24b))
RoIC = 2.55% (NOPAT 114.9m / Invested Capital 4.51b)
WACC = 9.03% (E(13.81b)/V(14.89b) * Re(9.55%) + D(1.08b)/V(14.89b) * Rd(2.95%) * (1-Tc(0.21)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 44.36%
Fair Price DCF = unknown (Cash Flow -3.44b)
EPS Correlation: 8.11 | EPS CAGR: -35.90% | SUE: -0.62 | # QB: 0
Revenue Correlation: 64.01 | Revenue CAGR: 28.00% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=-0.028 | Revisions Net=-5 | Analysts=9
EPS next Year (2026-12-31): EPS=1.49 | Chg30d=-0.084 | Revisions Net=-7 | Growth EPS=-8.7% | Growth Revenue=+19.3%